.png)
Are you confident you have access to all the genomic literature you need for variant interpretation?
A 2020 study* reported that laboratories disagreed on a variant’s classification 46% of the time, with 23% of those discrepancies being clinically impactful. Access to comprehensive genetic evidence is critical for proper diagnosis, especially when related to rare diseases.
Mastermind Genomic Intelligence Platform
The Most Comprehensive Source of Published Genomic Literature
Designed for Genomic Scientists
Reduce Turnaround Time
Quickly identify and review the genetic evidence, clinically prioritized with insight into each genomic article to speed variant interpretation for rare diseases.
Increase Diagnostic Yield
Access 100X more genomic evidence and 20X more variants than other sources to find relevant genomic articles, resolve more VUSs, and diagnose more patients.
Accelerate Throughput
Optimize your workflows by rapidly prioritizing variants of disease-causing genes, simplifying your analysis and enabling a more targeted approach.
Trusted by 20,000+ Users in 140+ Countries
Why is searching for genomic literature so hard?
Legacy Nomenclature Makes Genomic Evidence Hard to Find
More than 74% of the genomic variants in publications are still in non-normalized forms1, making citations hard to find, even in resources like NCBI’s PubMed.
Data is Hidden in the Body and Supplemental Text of Genomic Articles
Fewer than 6% of variants are identified in the title or abstract in NCBI’s PubMed, the remainder present in the full-text or supplemental files1.
Be ready for Rare Disease Day 2025 and learn how Genomenon can help your search.
